Trends in antimicrobial resistance of neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006

Sexually Transmitted Diseases

Volumn 38, Issue 11, 2011, Pages 1082-1086

  Lee, Hyukmin ^a   Hong, Seong Geun ^b   Soe, Younghee ^c   Yong, Dongeun ^c   Jeong, Seok Hoon ^c   Lee, Kyungwon ^c   Chong, Yunsop ^c  

^a Kwandong University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTIC ACID; BETA LACTAMASE; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE IV; PENICILLIN G; PHENYLALANINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; SPECTINOMYCIN; TETRACYCLINE;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GONORRHEA; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PLASMID;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PROSTITUTION; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; URETHRITIS;

EID: 80054096932     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31822e60a4     Document Type: Article

References (36)

1. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004; 80:255-263.
2. van Duynhoven YT. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect 1999; 1:455-464.
3. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2009. Available at: http://www.cdc.gov/std/stats09/surv2009- Complete.pdf.
4. Lee SJ, Cho YH, Ha US, et al. Sexual behavior survey and screening for chlamydia and gonorrhea in university students in South Korea. Int J Urol 2005; 12:187-193.
5. Lee SJ, Cho YH, Kim CS, et al. Screening for Chlamydia and gonorrhea by strand displacement amplification in homeless adolescents attending youth shelters in Korea. J Korean Med Sci 2004; 19:495-500.
6. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: The impending problem of resistance. Expert Opin Pharmacother 2009; 10:555-577.
7. Tapsall JW. Implications of current recommendations for thirdgeneration cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sex Transm Infect 2009; 85:256-258.
8. Lewis DA. The Gonococcus fights back: Is this time a knock out? Sex Transm Infect 2010; 86:415-421.
9. Kam KM, Lo KK, Ho NK, et al. Rapid decline in penicillinaseproducing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin Med 1995; 71:141-144.
10. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis 2007; 34:995-999. (Pubitemid 350158851)
11. Van Vranken M. Prevention and treatment of sexually transmitted diseases: An update. Am Fam Physician 2007; 76:1827-1832.
12. Matsumoto T. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae. Int J Antimicrob Agents 2008; 31(suppl 1):S35-S39.
13. Western Pacific Regional Antimicrobial Resistance Surveillance Programme. Sensitivity testing of Neisseria gonorrhoeae: methodologies for use for participants in the WHO Western Pacific Regional Resistance Surveillance Programme. The Western Pacific Regional Antimicrobial Resistance Surveillance Working Group Meeting; 9-13th December 1991; Hong Kong.
14. Bala M, Ray K, Gupta SM, et al. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J Antimicrob Chemother 2007; 60:582-586. (Pubitemid 47299872)
15. Tapsall JW, Limnios EA, Murphy D; Australian Gonococcal Surveillance Programme. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997-2006. J Antimicrob Chemother 2008; 61:150-155.
16. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010; 86:427-432.
17. Wang SA, Harvey AB, Conner SM, et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med 2007; 147:81-88. (Pubitemid 351664611)
18. WHO Western Pacific Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. Commun Dis Intell 2010; 34:1-7.
19. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148:606-613. (Pubitemid 351669134)
20. Lee K, Chong Y, Erdenechemeg L, et al. Incidence, epidemiology and evolution of reduced susceptibility to ciprofloxacin in Neisseria gonorrhoeae in Korea. Clin Microbiol Infect 1998; 4:627-633. (Pubitemid 28550333)
21. Lee K, Shin JW, Lim JB, et al, Chong Y. Emerging antimicrobial resistance, plasmid profile and pulsed-field gel electrophoresis pattern of the endonuclease-digested genomic DNA of Neisseria gonorrhoeae. Yonsei Med J 2000; 41:381-386. (Pubitemid 30670715)
22. Yong D, Kim TS, Choi JR, et al. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries. J Antimicrob Chemother 2004; 54:451-455. (Pubitemid 39177469)
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. Wayne, PA: CLSI, 2006.
24. Wikipedia. Stratified sampling. March 7, 2011. Available at: http://en.wikipedia.org/wiki/Stratified-sampling. Accessed March 9, 2011.
25. Tanaka M, Nakayama H, Haraoka M, et al. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacinresistant isolates in Japan, 1993 to 1998. J Clin Microbiol 2000; 38:521-525. (Pubitemid 30082634)
26. Gerbase AC, Rowley JT, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74(suppl 1):S12-S16.
27. Korean Centers for Disease Control and Prevention. Sentinel surveillance report. Commun Dis Monthly Rep 2007; 18:14.
28. Tzelepi E, Avgerinou H, Flemetakis A, et al. Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece. Sex Transm Dis 2010; 37:115-120.
29. Jakopanec I, Borgen K, Aavitsland P. The epidemiology of gonorrhea in Norway, 1993-2007: Past victories, future challenges. BMC Infect Dis 2009; 9:33.
30. De Jongh M, Dangor Y, Adam A, et al. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa-Implications for treatment guidelines. Int J STD AIDS 2007; 18:697-699. (Pubitemid 351738901)
31. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51(RR-6):1-78.
32. Vernel-Pauillac F, Hogan TR, Tapsall JW, et al. Quinolone Resistance in Neisseria gonorrhoeae: Rapid genotyping of quinolone resistance-determining regions in gyrA and parC genes by melting curve analysis predicts susceptibility. Antimicrob Agents Chemother 2009; 53:1264-1267.
33. Rouquette-Loughlin C, Dunham SA, Kuhn M, et al. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol 2003; 185:1101-1106. (Pubitemid 36139470)
34. Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 2003; 36:502-509. (Pubitemid 36315803)
35. Chacko MR, Wiemann CM, Smith PB. Chlamydia and gonorrhea screening in asymptomatic young women. J Pediatr Adolesc Gynecol 2004; 17:169-178. (Pubitemid 38581970)
36. Martin IM, Ison CA, Aanensen DM, et al. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J Infect Dis 2005; 192:1191-1195. (Pubitemid 41368418)